Oppenheimer & Co. Inc. Takes $407,000 Position in BridgeBio Pharma, Inc. $BBIO

Oppenheimer & Co. Inc. acquired a new position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 7,845 shares of the company’s stock, valued at approximately $407,000. Get BridgeBio Pharma alerts: Several other large investors have also recently added to or reduced their stakes in the business. Jones Financial Companies Lllp bought a new position in shares of BridgeBio Pharma in the firs ...